Apha/beta T and CD19+ cell depletion using CliniMACS device

DEVICE2 trials

Sponsors

Children's Hospital of Philadelphia

Conditions

Bone Marrow Failure SyndromeImmune Dysregulation SyndromesImmunodeficienciesLeukemia

Phase 2

Alpha/Beta T and CD19+ Depleted Peripheral Stem Cells for Patients With Primary Immunodeficiencies

Active, not recruitingNCT02990819

Children's Hospital of PhiladelphiaImmune Dysregulation Syndromes, Immunodeficiencies

Start: 2016-12-31End: 2027-12-31Target: 60Updated: 2025-11-07

Unknown Phase

Expanded Access Protocol Using Alpha/Beta T and CD19+ Depleted PBSC

Children's Hospital of PhiladelphiaBone Marrow Failure Syndrome, Immunodeficiencies, Leukemia

Updated: 2026-07-08

Related Papers

Ex Vivo T-Cell Receptor αβ +/CD19 +depletion of Peripheral Stem Cell Grafts for Pediatric Patients with Bone Marrow Failure (BMF) Undergoing Unrelated Donor Transplantation

Blood2021-11-05